Tricida Announces Publication of Positive TRC101 Pivotal Trial Results in The Lancet by mparnell | Mar 11, 2019 | Portfolio News
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results by mparnell | Mar 11, 2019 | Portfolio News
Tricida to Report Fourth Quarter and Full-Year 2018 Financial Results and Host Conference Call and Webcast on Thursday, March 28, 2019 by mparnell | Mar 7, 2019 | Portfolio News
Akebia Therapeutics to Host Fourth Quarter and Full-Year 2018 Investor Update Call and Webcast by mparnell | Mar 6, 2019 | Portfolio News
Axonics® Announces Fourth Quarter and Full Year 2018 Financial Results and Operational Update by mparnell | Mar 5, 2019 | Portfolio News